Clonazepam
Klonopin (clonazepam) is a small molecule pharmaceutical. Clonazepam was first approved as Klonopin on 1982-01-01. It is used to treat absence epilepsy, bipolar disorder, dysarthria, lennox gastaut syndrome, and myoclonic epilepsies amongst others in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-3, gamma-aminobutyric acid receptor subunit alpha-2, and gamma-aminobutyric acid receptor subunit alpha-1.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Klonopin (generic drugs available since 1996-09-10, discontinued: Klonopin rapidly disintegrating)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Clonazepam
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| KLONOPIN | CHEPLAPHARM Arzneimittel | N-017533 RX | 1982-01-01 | 3 products, RLD |
Show 2 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| clonazepam | ANDA | 2023-05-30 |
| klonopin | New Drug Application | 2023-01-26 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| absence epilepsy | HP_0011147 | D004832 | G40.A |
| bipolar disorder | EFO_0000289 | D001714 | F30.9 |
| dysarthria | HP_0001260 | D004401 | — |
| lennox gastaut syndrome | — | D065768 | G40.81 |
| myoclonic epilepsies | EFO_1001900 | D004831 | G40.4 |
| neuralgia | EFO_0009430 | D009437 | — |
| panic disorder | EFO_0004262 | D016584 | F41.0 |
| restless legs syndrome | EFO_0004270 | D012148 | G25.81 |
| schizophrenia | EFO_0000692 | D012559 | F20 |
| seizures | HP_0007359 | D012640 | G40.4 |
Show 1 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | — | 1 | 2 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | 1 | — | 1 | 2 |
| Coronary disease | D003327 | — | — | 1 | — | 1 | 2 | ||
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | — | 1 | 2 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | — | 1 | 2 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CLONAZEPAM |
| INN | clonazepam |
| Description | Clonazepam is 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation. It has a role as an anticonvulsant, a GABA modulator and an anxiolytic drug. It is a 1,4-benzodiazepinone and a member of monochlorobenzenes. |
| Classification | Small molecule |
| Drug class | antianxiety agents (diazepam type) |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 |
Identifiers
| PDB | — |
| CAS-ID | 1622-61-3 |
| RxCUI | 2598 |
| ChEMBL ID | CHEMBL452 |
| ChEBI ID | 3756 |
| PubChem CID | 2802 |
| DrugBank | DB01068 |
| UNII ID | 5PE9FDE8GB (ChemIDplus, GSRS) |
Target
Agency Approved
GABRA3
GABRA3
GABRA2
GABRA2
GABRA1
GABRA1
Organism
Homo sapiens
Gene name
GABRA3
Gene synonyms
NCBI Gene ID
Protein name
gamma-aminobutyric acid receptor subunit alpha-3
Protein synonyms
GABA(A) receptor subunit alpha-3, GABA(A) receptor, alpha 3, gamma-aminobutyric acid (GABA) A receptor, alpha 3, gamma-aminobutyric acid type A receptor alpha3 subunit, gamma-animobutyric acid (GABA) A receptor, alpha 3
Uniprot ID
Mouse ortholog
Gabra3 (14396)
gamma-aminobutyric acid receptor subunit alpha-3 (P26049)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 12,171 documents
View more details
Safety
Black-box Warning
Black-box warning for: Clonazepam, Klonopin
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
24 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more